Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre study. - Paci V; Zabotti A; Fontanarosa A; Celletti E; Lopalco G; Foti R; Di Zio R; Perrotta FM; Di Penta M; Visalli E; Agostinelli A; Marchionni G; et al. (RMD open, 2026)